MET Oncogene Enhances Pro-Migratory Functions by Counteracting NMDAR2B Cleavage

Area of Science:

• Neuroscience
• Molecular Biology
• Cancer Research

Background:

• The N-methyl-D-aspartate receptor (NMDAR) is implicated in cancer cell invasion.
• A physical interaction between NMDAR and the hepatocyte growth factor (HGF) receptor, MET, has been previously observed.
• The precise molecular mechanisms governing the NMDAR/MET interaction and its functional consequences in cancer remain largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the interaction between NMDAR and MET.
• To investigate the role of MET in regulating NMDAR stability and function.
• To determine how the MET-NMDAR axis influences cancer cell migration.

Main Methods:

• Co-transfection of NMDAR2B and MET constructs in cells.
• Assessment of NMDAR2B proteolytic processing and protein levels.
• Inhibition of autophagy and lysosomal pathways.
• Analysis of MET kinase activity and its effect on NMDAR2B.
• Evaluation of cell migration assays.

Main Results:

• NMDAR2B undergoes proteolytic processing to a 100 kDa form, which is stabilized by MET co-expression.
• MET kinase activity is essential for protecting NMDAR2B from cleavage.
• MET inhibits the autophagic lysosomal proteolysis of NMDAR2B by decreasing cathepsin levels and is dependent on mTOR signaling.
• MET utilizes NMDAR2B to promote cancer cell migration.

Conclusions:

• MET kinase activity stabilizes NMDAR2B by preventing its lysosomal degradation, thereby enhancing cancer cell migration.
• The MET-mediated protection of NMDAR2B from autophagy represents a novel mechanism contributing to cancer cell invasiveness.
• Targeting the MET-NMDAR interaction could offer a therapeutic strategy to inhibit cancer progression.